Investors have been pouring into rapidly developing AI tech names over the past few months, and this is likely just the beginning.  According to Grand View Research, the global artificial intelligence market reached a valuation of $136.55 billion in 2022.  It’s projected that by 2030 the industry...
Cyclical stocks suffered  in 2022, but 2023 could be a banner year for growth stocks as inflation cools and the Fed eventually finishes the rate hiking cycle. Today we’re focusing on a deep value growth name that seems to be poised for a comeback as cyclicals regain...
Regardless of what’s happening elsewhere in the market, biopharma is a great place to look for stocks to pack into your portfolio because there’s always an illness that can be treated more effectively in the future than it is being treated today.  Our stock...
The market rally this year has been impressive. However, last week uncertainty and volatility returned to markets.   The S&P 500 was down 1.1% on the week, its worst week of the year thus far. The Nasdaq posted a steeper decline of 2.4%, while the...
One area of the market where stocks can be found to produce 10x, even 20x returns, regardless of what’s happening elsewhere in the market, is biotech. Looking at the performance of the past ten years, if the biotechnology industry were a sector, it would be the...